Literature DB >> 23873877

Anticarbamylated protein (anti-CarP) antibodies are present in sera of juvenile idiopathic arthritis (JIA) patients.

P C E Hissink Muller1, J Anink, J Shi, E W N Levarht, T H C M Reinards, M H Otten, M J D van Tol, C M Jol-van der Zijde, D M C Brinkman, C F Allaart, E P Hoppenreijs, Y Koopman-Keemink, S S M Kamphuis, K Dolman, J M van den Berg, M A J van Rossum, L W A van Suijlekom-Smit, M W Schilham, T W J Huizinga, R E M Toes, R Ten Cate, L A Trouw.   

Abstract

Entities:  

Keywords:  Ant-CCP; Chemokines; Juvenile Idiopathic Arthritis

Mesh：

Substances：

Year:  2013        PMID： 23873877     DOI： 10.1136/annrheumdis-2013-203650

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  11 in total

Review 1.  Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis.

Authors:  Leendert A Trouw; Theo Rispens; Rene E M Toes
Journal:  Nat Rev Rheumatol       Date:  2017-03-09       Impact factor: 20.543

2.  Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis.

Authors:  Ryan W Gan; Leendert A Trouw; Jing Shi; René E M Toes; Tom W J Huizinga; M Kristen Demoruelle; Jason R Kolfenbach; Gary O Zerbe; Kevin D Deane; Jess D Edison; William R Gilliland; Jill M Norris; V Michael Holers
Journal:  J Rheumatol       Date:  2015-01-15       Impact factor: 4.666

3.  Carbamylation of immunoglobulin abrogates activation of the classical complement pathway.

Authors:  Catalin Koro; Ewa Bielecka; Anders Dahl-Knudsen; Jan J Enghild; Carsten Scavenius; Johan G Brun; Veronika Binder; Annelie Hellvard; Brith Bergum; Roland Jonsson; Jan Potempa; Anna M Blom; Piotr Mydel
Journal:  Eur J Immunol       Date:  2014-10-20       Impact factor: 5.532

4.  Factors associated with improvement in disease activity following initiation of etanercept in children and young people with Juvenile Idiopathic Arthritis: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study.

Authors:  Lianne Kearsley-Fleet; Rebecca Davies; Mark Lunt; Taunton R Southwood; Kimme L Hyrich
Journal:  Rheumatology (Oxford)       Date:  2015-12-31       Impact factor: 7.580

5.  Meta-Analysis: Diagnostic Accuracy of Anti-Carbamylated Protein Antibody for Rheumatoid Arthritis.

Authors:  Liubing Li; Chuiwen Deng; Si Chen; Shulan Zhang; Ziyan Wu; Chaojun Hu; Fengchun Zhang; Yongzhe Li
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

6.  Antibodies against carbamylated proteins are present in primary Sjögren's syndrome and are associated with disease severity.

Authors:  Brith Bergum; Catalin Koro; Nicolas Delaleu; Magne Solheim; Annelie Hellvard; Veronika Binder; Roland Jonsson; Valeria Valim; Daniel S Hammenfors; Malin V Jonsson; Piotr Mydel
Journal:  Ann Rheum Dis       Date:  2015-09-08       Impact factor: 19.103

Review 7.  Autoantibodies in the Pathogenesis, Diagnosis, and Prognosis of Juvenile Idiopathic Arthritis.

Authors:  Shawn A Mahmud; Bryce A Binstadt
Journal:  Front Immunol       Date:  2019-01-14       Impact factor: 7.561

Review 8.  From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis.

Authors:  Chao-Yi Wu; Huang-Yu Yang; Shue-Fen Luo; Jenn-Haung Lai
Journal:  Int J Mol Sci       Date:  2021-01-12       Impact factor: 5.923

9.  Anti-Carbamylated Protein (Anti-CarP) Antibodies in Patients Evaluated for Suspected Rheumatoid Arthritis.

Authors:  Vincent Ricchiuti; Kelly Y Chun; Jane M Yang; Mary Ann Aure; Luis Gomez; Gary L Norman; Michael Mahler
Journal:  Diagnostics (Basel)       Date:  2022-07-08

Review 10.  Protein carbamylation in kidney disease: pathogenesis and clinical implications.

Authors:  Sahir Kalim; S Ananth Karumanchi; Ravi I Thadhani; Anders H Berg
Journal:  Am J Kidney Dis       Date:  2014-07-16       Impact factor: 8.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.